7. Insulinpumpentherapie, künstliches Pankreas, Zell- und Gentherapie

Zurück zum Zitat Bachran R, Beyer P, Klinkert C, Heidtmann B, Rosenbauer J, Holl RW; German/Austrian DPV Initiative; German Pediatric CSII Working Group; BMBF Competence Network Diabetes (2012) Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adults. Pediatr Diabetes 13: 1–5 Bachran R, Beyer P, Klinkert C, Heidtmann B, Rosenbauer J, Holl RW; German/Austrian DPV Initiative; German Pediatric CSII Working Group; BMBF Competence Network Diabetes (2012) Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adults. Pediatr Diabetes 13: 1–5

Zurück zum Zitat Danne T, Battelino T, Jarosz-Chobot P, Kordonouri O, Pánkowska E, Ludvigsson J, Schober E, Kaprio E, Saukkonen T, Nicolino M, Tubiana-Rufi N, Klinkert C, Haberland H, Vazeou A, Madacsy L, Zangen D, Cherubini V, Rabbone I, Toni S, de Beaufort C, Bakker-van Waarde W, van den Berg N, Volkov I, Barrio R, Hanas R, Zumsteg U, Kuhlmann B, Aebi C, Schumacher U, Gschwend S, Hindmarsh P, Torres M, Shehadeh N, Phillip M; PedPump Study Group (2008) Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries. Diabetologia 51: 1594–1601 Danne T, Battelino T, Jarosz-Chobot P, Kordonouri O, Pánkowska E, Ludvigsson J, Schober E, Kaprio E, Saukkonen T, Nicolino M, Tubiana-Rufi N, Klinkert C, Haberland H, Vazeou A, Madacsy L, Zangen D, Cherubini V, Rabbone I, Toni S, de Beaufort C, Bakker-van Waarde W, van den Berg N, Volkov I, Barrio R, Hanas R, Zumsteg U, Kuhlmann B, Aebi C, Schumacher U, Gschwend S, Hindmarsh P, Torres M, Shehadeh N, Phillip M; PedPump Study Group (2008) Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries. Diabetologia 51: 1594–1601

Zurück zum Zitat Danne T, Kordonouri O, Thomas A (2014) Konzept und Aufbau eines artifiziellen Pankreas (Closed-Loop-System). Diabetes Stoffw Herz 23: 27–36 Danne T, Kordonouri O, Thomas A (2014) Konzept und Aufbau eines artifiziellen Pankreas (Closed-Loop-System). Diabetes Stoffw Herz 23: 27–36

Zurück zum Zitat Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, Biester T, Stefanija MA, Muller I, Nimri R, Danne T (2013) Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 368: 824–833CrossRef Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, Biester T, Stefanija MA, Muller I, Nimri R, Danne T (2013) Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 368: 824–833CrossRef

Zurück zum Zitat Phillip M, Battelino T, Rodriguez H, Danne T, Kaufman F; European Society for Paediatric Endocrinology; Lawson Wilkins Pediatric Endocrine Society; International Society for Pediatric and Adolescent Diabetes; American Diabetes Association; European Association for the Study of Diabetes (2007) Use of insulin pump therapy in the pediatric agegroup: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 30: 1653–1662CrossRef Phillip M, Battelino T, Rodriguez H, Danne T, Kaufman F; European Society for Paediatric Endocrinology; Lawson Wilkins Pediatric Endocrine Society; International Society for Pediatric and Adolescent Diabetes; American Diabetes Association; European Association for the Study of Diabetes (2007) Use of insulin pump therapy in the pediatric agegroup: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 30: 1653–1662CrossRef

Zurück zum Zitat Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E (2015) Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev. doi: 10.1002/dmrr.2653 Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E (2015) Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev. doi: 10.1002/dmrr.2653

Zurück zum Zitat Steineck I, Cederholm J, Eliasson B, Rawshani A, Eeg-Olofsson K, Svensson AM, Zethelius B, Avdic T, Landin-Olsson M, Jendle J, Gudbjörnsdóttir S; Swedish National Diabetes Register (2015) Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study. Brit Med J 350: h3234 Steineck I, Cederholm J, Eliasson B, Rawshani A, Eeg-Olofsson K, Svensson AM, Zethelius B, Avdic T, Landin-Olsson M, Jendle J, Gudbjörnsdóttir S; Swedish National Diabetes Register (2015) Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study. Brit Med J 350: h3234